ICW Investment Advisors LLC Buys 39 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ICW Investment Advisors LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,314 shares of the healthcare conglomerate’s stock after acquiring an additional 39 shares during the quarter. ICW Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,178,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Wellington Shields Capital Management LLC increased its position in shares of UnitedHealth Group by 149.2% during the second quarter. Wellington Shields Capital Management LLC now owns 7,232 shares of the healthcare conglomerate’s stock worth $3,683,000 after buying an additional 4,330 shares during the period. Blue Barn Wealth LLC grew its holdings in UnitedHealth Group by 13.8% during the 2nd quarter. Blue Barn Wealth LLC now owns 633 shares of the healthcare conglomerate’s stock worth $322,000 after acquiring an additional 77 shares during the period. Arizona State Retirement System lifted its stake in shares of UnitedHealth Group by 0.7% in the 2nd quarter. Arizona State Retirement System now owns 267,298 shares of the healthcare conglomerate’s stock valued at $136,124,000 after purchasing an additional 1,875 shares during the period. Childress Capital Advisors LLC increased its holdings in UnitedHealth Group by 11.7% in the second quarter. Childress Capital Advisors LLC now owns 2,422 shares of the healthcare conglomerate’s stock worth $1,233,000 after purchasing an additional 254 shares in the last quarter. Finally, Hendershot Investments Inc. boosted its holdings in shares of UnitedHealth Group by 3.1% during the 2nd quarter. Hendershot Investments Inc. now owns 41,260 shares of the healthcare conglomerate’s stock worth $21,012,000 after buying an additional 1,228 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on UNH shares. Argus lifted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. UBS Group upped their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Royal Bank of Canada boosted their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Truist Financial boosted their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $614.17.

Check Out Our Latest Stock Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

UNH traded down $0.87 during trading on Friday, hitting $594.62. 292,518 shares of the company traded hands, compared to its average volume of 4,054,651. The firm has a market cap of $549.08 billion, a P/E ratio of 36.40, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The stock’s fifty day moving average is $557.22 and its 200 day moving average is $514.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.14 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.67 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.